Co-Diagnostics Confirms Flu Test Performance Against This Season’s H3N2 Strain
In silico analysis of 3,900 influenza sequences shows comparable sensitivity for the test against the subclade K variant currently circulating.
Read MorePosted by CLP Edit Staff | Dec 17, 2025 | Flu & Respiratory Infections |
In silico analysis of 3,900 influenza sequences shows comparable sensitivity for the test against the subclade K variant currently circulating.
Read MorePosted by CLP Edit Staff | Dec 17, 2025 | Molecular Diagnostic Analyzers |
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
Read MorePosted by Alyx Arnett | Dec 17, 2025 | Diagnostic Technologies |
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Read MorePosted by CLP Edit Staff | Dec 16, 2025 | Infectious Diseases |
The collaboration aims to create a non-invasive diagnostic for Pseudomonas aeruginosa using miniaturized gas chromatography-mass spectrometry technology.
Read MorePosted by CLP Edit Staff | Dec 12, 2025 | Anatomic Pathology |
The study consolidating data from six published studies confirms the test outperforms traditional pathology or clinical factors alone in identifying esophageal cancer risk.
Read More